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Abstract: The development of effective high-throughput screening 
assays has contributed greatly to the wealth of designer enzymes 
available, by enabling rapid identification of desired variants from 
large mutant libraries. Here, we report a general and operationally 
simple end-point assay for transaminases that enables the screening 
of both amine donors and acceptors in liquid phase. The 
spectrophotometric-based screen exploits the amine donor 2-
aminoethylaniline (2-AEA) and relies on reaction of in situ generated 
indole with Ehrlich’s reagent. The assay has also been adapted to 
allow screening in the reverse direction by addition of indole and 
subsequent spectrophotometric analysis. Importantly, the screen 
provides qualitative information on the enantio-preference of the 
individual biocatalysts. To increase the assay throughput, an 
engineered expression strain (E. coli BL21(DE3) ΔtnaA) lacking 
tryptophanase activity, was generated to enable reliable and direct 
evaluation of individual colonies arrayed on agar plates. 
The development and application of enzymes for the sustainable 
production of (chiral) molecules remains a thriving area of 
research.[1] Access to efficient, low-cost synthetic gene synthesis 
and DNA sequencing, as well as major advances in protein 
engineering, have led to the wealth of ‘designer biocatalysts’ that 
have been developed in academic and industrial laboratories.  
Directed evolution in particular has enabled rapid tailoring of 
enzymes, providing catalysts with altered substrate scope, 
stereoselectivity and enhanced stability,[2] and making it possible 
to consider enzymes alongside more traditional catalysts when 
designing routes to complex molecules. The directed evolution 
strategy mimics natural evolution and involves subjecting a gene 
to iterative rounds of mutagenesis followed by selection, until a 
catalyst with the desired activity is identified.[3] The success of the 
approach relies heavily on efficient screening strategies to allow 
detection of improved variants, and the design of such screens 
has been the subject of much research.[4] The significant impact 
that directed evolution has had on the development of 
synthetically useful enzymes and the consequent expansion of 
the catalytic toolbox has recently been recognized with the award 
of the Nobel Prize in Chemistry.[5] 
The prevalence of chiral amines in natural products, 
(agro)chemicals and active pharmaceutical ingredients [1b, 1d, 6]  
has led to enormous interest in the engineering and evolution of 
amine transaminases (ATAs) for the production of such high-
value compounds. These pyridoxal-5'-phosphate dependent 
enzymes are capable of catalyzing the conversion of aldehydes 
and pro-chiral ketones to the corresponding (chiral) amines.[1b, 6] 
Although wild-type (WT) ATAs tend to have a somewhat narrow 
substrate scope, there are many impressive examples of enzyme 
engineering that have provided catalysts with a significantly 
broader substrate range and with suitable properties for industrial 
application.[1b, 6a-b, 7] However, assay development with ATAs 
presents a particular challenge, as a primary amine and carbonyl 
compound are both consumed and produced during the reaction. 
This often means that the design of a general, substrate 
independent assay to aid engineering is not straightforward.  
To simplify engineering, a number of enzymatic and non-
enzymatic assays have been developed that focus on monitoring 
the formation of the product or co-product. Enzymatic cascades, 
exploiting amino acid dehydrogenases[8] and amino acid oxidases 
in combination with horseradish peroxidase,[9] have been 
successfully developed to detect specific amino or carbonyl 
products. However, despite the elegance of many of these 
approaches, the use of multiple enzymes can complicate assays 
and limit their practical application. Non-enzymatic assays have 
also been developed, which rely on spectroscopic,[10] 
fluorescent[11] or colorimetric[12] detection of (co)products. One of 
the most established and successful assays relies on the 
spectrophotometric detection of acetophenone, when the widely 
accepted amine donor, -methylbenzylamine, is employed.[10] 
However, the assay has a number of drawbacks, which means 
the development of an alternative screening strategy is extremely 
important. Firstly, as the protein contributes to the initial 
absorbance, there are limitations to the amount of protein that can 
be used in this assay. Secondly, the screen is typically only used 
for assessing the conversion of -methylbenzylamine to 
acetophenone in the presence of low absorbing amine acceptors 
and does not routinely allow screening of a broad range of UV 
active acceptors or of alternative amine donors. Furthermore, 
successful application of this assay for large library design and 
evaluation often relies on expensive robotics platforms and cannot 
be used for assessing colonies arrayed on agar plates. 
In an effort to overcome some of the challenges associated 
with the ‘acetophenone assay’, our group previously reported the 
application of the ‘smart’ diamine donor, o-xylylenediamine, which 
upon transamination, forms an unstable isoindole coproduct that 
rapidly polymerizes.[13] The dark polymer produced provides a 
useful method for detecting ATA activity and has been 
demonstrated to be effective for both liquid and solid-phase 
assays.[13, 14] However, while the formation of this insoluble 
polymer provides a useful qualitative assay, it prevents 
quantitative analysis and therefore its application is limited. 
Although a number of the assays discussed above can be used 
to identify catalysts with the desired activity and stereoselectivity, 
none represent a general approach for the quantitative detection 
of novel amine donors and ketone acceptors in both liquid and 
solid phase. Here, we report an operationally simple and accurate 
quantitative assay that can be used to identify novel amine or 
carbonyl substrates in liquid phase, and also allows identification 
of enzymes with the desired stereoselectivity. The broad utility of 
the assay relies on the spectrophotometric monitoring of in situ 
produced or exogenously added indole (1), which reacts with 
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Ehrlich’s reagent[15] to produce β-bis(indolyl)methane 3 (Scheme 
1). To increase the utility and throughput of the assay, we have 
also developed an engineered E. coli strain that can be employed 
for direct colony-based screening. 
2-Aminoethylaniline (2-AEA) (4) (Table 1), was synthesized 
from commercially available (2-nitrophenyl)acetonitrile (see SI). It 
was envisaged that employing (4) as an amine donor would lead 
to an indole coproduct that could be exploited for high-throughput 
screening. While indole itself is not colored and it is not possible 
to follow its formation spectrophotometrically under 
biotransformation conditions, it readily reacts with Ehrlich’s 
reagent to produce compound (3).[15,16] This reagent, containing 
4-DMAB (2), concentrated HCl and alcohol, was historically used 
to test for the presence of indole in bacterial cultures,[16] and many 
variations on the original conditions have since been employed.[15, 
17]  
 
 
 
 
 
 
Scheme 1. Reaction of indole (1) with 4-dimethylaminobenzaldehyde (4-DMAB) 
(2), a key component in Ehrlich’s reagent, to give (3). 
 
Initial efforts focused on investigating whether 2-AEA (4) 
was readily accepted as an amine donor by (S)-selective 3HMU 
and commercially available ATA-113 (Table 1). Four ketones (5-
8) were selected to evaluate this transformation. The highest 
conversions were achieved with ketone (7), where 2 equivalents 
of 2-AEA were sufficient to reach a conversion of 69% with ATA-
113 and 23% for 3HMU.[18]  
 
Table 1. Conversion of ketones (5-8) (5 mM) to the corresponding amines in the 
presence of 2-AEA (10 mM). 
 
 
 
 
 
 
 
 
 
 
Entry Ketone Enzyme 
 
Equivalents 
(4) 
% Conv. 
 
1 5 ATA113 2 8 
2 6 ATA113 2 62 
3 7 ATA113 2 69 
4 8 ATA113 2 <5 
5 7 3HMU 2 23 
Conversion is based on the consumption of starting material. 
 
Next, we focused on the development of a quantitative 
liquid-phase assay that would enable rapid identification of TAs 
with activity towards ketones, by exploiting 2-AEA in combination 
with Ehrlich’s reagent. Biotransformations of (4-
fluorophenyl)acetone (7), catalyzed by ATA-113 and 3HMU, were 
monitored at various time points over a 24 hour period, to ensure 
that the assay was quantitative over a wide range of conversions 
(Figure 1). Controls were used to generate a standard curve, 
where absorbance directly corresponds to conversion (see SI). 
Inclusion of these controls alongside the biotransformations was 
necessary to generate a reliable standard curve and enable 
conversions to be accurately calculated. Plate 1 shows the 
biotransformations of ketone (7) with ATA-113. Color intensity 
increases across columns A-F as the biotransformation 
progresses, due to the increasing concentration of indole 
available to react with 4-DMAB. The same trend is apparent in 
plate 2, containing WT 3HMU. However, the lower color intensity 
across the wells suggests a significantly lower conversion. 
Spectrophotometric analysis supported this trend and allowed the 
calculation of conversion values (Table 2). To confirm the 
reliability of the conversions predicted from the spectrometer, the 
same biotransformations were also analyzed by GC/FID (Table 
2). Even at low conversions, the two independently calculated 
values across all time point are closely comparable. 
Compound 3 was synthesized chemically and compared to 
the product isolated from a typical biotransformation and 
subsequent reaction with Ehrlich’s reagent. While NMR data 
confirms that compound 3 is formed under these reaction 
conditions, the exact nature of the molecule giving rise to the 
intense color and strong spectrophotometric signal is not fully 
understood and has not been investigated in this work.  
 
 
Figure 1. Acceptor screen: biotransformations with (4-fluorophenyl)acetone 
(7) (5 mM) and 2-AEA (15 mM) at various time points, developed using Ehrlich’s 
reagent. Plate 1 & 2: (4-fluorophenyl)acetone (7) (5 mM), 2-AEA (15 mM), ATA-
113 (2.5 mg/mL) or 3HMU (2% lysate). Plate 3 & 4: same as plate 1 & 2 but 
enzyme omitted and indole added (0 mM - 5 mM). L1-3 are replicates. Control 
1 and 2 differ only in reaction setup for the commercial and WT enzyme. See SI 
for details.  
Table 2. Acceptor screen: Conversion of (4-fluorophenyl)acetone (7) (5 mM) 
to the corresponding amine using ATA-113 or 3HMU, in the presence of 2-AEA 
(15 mM), as determined by colorimetric assay and GC-FID 
Entry Reaction 
Time (h) 
Abs. 
% conv. 
GC 
% conv. 
ATA-113    
1 1  19 25 
2 3  38 43 
3 6  60 64 
4 24  81 84 
    
3HMU    
5 1  <5 <5 
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6 3  <5 <5 
7 6  <5 6 
8 24  26 23 
GC conversion is based on the disappearance of starting material. See SI for 
details 
 
It became apparent that the Ehrlich test could be reversed to 
develop a useful amine donor screen, if 4-DMAB were employed 
as a universal amine acceptor. Assuming a given transaminase 
accepted 4-DMAB as a substrate, the performance of the enzyme 
with a range of amino donor substrates could be evaluated, by 
testing biotransformations for the presence of residual 4-DMAB, 
which would react with added indole to give the same 
bis(indolyl)methane product (3) (Scheme 2).  In this case, lower 
absorbance values would be indicative of better acceptance of the 
amine donor by the enzyme. 
Scheme 2. Strategy for screening amine donors by exploiting 4-DMAB as the 
acceptor.  
 
The assay was performed using commercially available (S)-
selective ATA-256, (S)-MBA and 4-DMAB, and monitored at 
various points over a 24 h period (Figure 2). The reactions were  
developed using a combination of indole and HCl and interestingly, 
exposure to light accelerated color formation (see SI for details). 
As the biotransformation incubation time increases (A-G across 
plate 1), there is a clear decrease in color intensity, due to a 
decrease in the concentration of residual 4-DMAB available to 
react with the added indole. Indole standards were run alongside 
the biotransformations each time and used to generate a standard 
curve. The spectrophotometrically predicted values correlated 
well with conversions measured independently on the GC (Table 
3) at both low and high conversions. 
 
 
 
Figure 2. Donor screen. Plate 1: biotransformations with (S)-MBA (5 mM), 4-
DMAB (5 mM) and ATA-256 (1 mg/mL), monitored over 24 hours, and 
developed using Ehrlich’s reagent. H = no enzyme control. Plate 2: 4-DMAB 
standards with enzyme omitted. L1-3 are replicates. 
Table 3. Donor screen: conversion of (S)-MBA (5 mM) to acetophenone (5) in 
the presence of 4-DMAB (5 mM) and ATA-256, HEPES (100 Mm, pH 7.5), 30°C. 
Entry Reaction 
time 
Abs. 
% conv. 
GC 
% conv. 
ATA-256    
1 6 min <5 <5 
2 30 min 14 14 
3 1 hour 27 23 
4 2 hours 41 40 
5 3 hours 51 54 
6 6 hours 67 65 
7 24 hours 78 82 
GC conversion is based on the disappearance of (S)-MBA and the accumulation 
of acetophenone. See SI for details.  
 
Six WT ATAs[19] were selected to demonstrate that the same 
assay can also be employed to screen libraries of transaminases 
in order to determine their enantio-preference. Figure 3 shows 
biotransformations with three (R)- and three (S)-selective ATAs in 
the presence of 4-DMAB and both (R)-MBA and (S)-MBA. 
HEWT[19a] and CV[19b] show high conversions with (S)-MBA of 
81% and 80% respectively (Table 4), and the decrease in colour 
is visually apparent in the wells and quantitatively measurable 
spectrophotometrically. Significantly lower conversions were 
achieved with the other ATAs but are still measurable using this 
assay. As before, the UV predicted conversion compare well with 
those measure by GC, even at low conversions (Table 4).  
 
 
Figure 3.  Enantiopreference screen. biotransformations with (R)- or (S)-MBA 
(5 mM), 4-DMAB (5 mM), cell lysate (50uL), 24 h, and developed using Ehrlich’s 
reagent. Reactions are performed in triplicate. Standards contain 4-DMAB (5 
mM) and varying concentrations of (S)-MBA (enzyme omitted). See SI for 
details.  
 
Table 4. Enantio-preference screen: conversion of (R)- or (S)-MBA (5 mM) to 
acetophenone in the presence of 4-DMAB (5 mM), Kpi (100 mM, pH 8), 30°C 
determined by colorimetric assay and GC-FID 
Enzyme (R)-MBA 
Abs. 
% conv. 
(R)-MBA 
GC 
% conv. 
(S)-MBA 
Abs. 
% conv. 
(S)-MBA 
GC 
% conv. 
AspOry <1 <1 <1 <1 
HypNep 10 7 6 nd 
MycVan 28 27 4 <1 
3FCR Nd <1 3 9 
HEWT <1 <1 73 81 
CV <1 <1 70 80 
GC conversion is based on the disappearance of starting material. See SI for 
details. nd=not detected. See Table S1 for information on standard deviation 
values. 
 
 
In order to expand the utility of this assay, we sought to 
develop a colony-based screen which would enable large variant 
libraries to be evaluated in a high-throughput manner. However, 
indole is produced endogenously in indole-positive bacteria by the 
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action of the enzyme tryptophanase (EC 4.1.99.1), which 
hydrolytically cleaves tryptophan to give indole, pyruvate and 
ammonia.[20]  In E. coli (an indole-positive bacterium), including 
the commonly used expression strain BL21(DE3), the enzyme is 
encoded by the gene tnaA.[21] Initial studies showed that it was not 
possible to distinguish indole generated via this pathway from 
indole produced as a coproduct in the biotransformation with 2-
AEA as the donor. To enable the use of this expression strain for 
library generation and high-throughput screening, it was first 
necessary to remove the tryptophanase activity from the host 
strain. The in-frame gene deletion method of Link et al.[22] was 
employed, whereby the gene open reading frame is removed in 
its entirety, minimising the likelihood of polar effects on other 
genes in the operon, and ensuring no antibiotic resistance marker 
remains. The latter means that any protein expression plasmid 
may be subsequently used for the generation of variant 
transaminase libraries.   
The reagent, p-dimethylaminocinnamaldehyde 
(DMACA),[23]  was employed as an alternative to DMAB during 
solid-phase assay development (Figure 4). To eliminate 
interference from endogenous pyruvate produced within the 
bacterial cells, a pre-incubation step was performed.[24] When 
cells were exposed to the amine donor (2-AEA), but without 
addition of external pyruvate substrate, BL21(DE3) colonies 
rapidly turned blue (Plate 1), while BL21(DE3) ΔtnaA remained 
pink. Only in the presence of the pyruvate substrate did the ΔtnaA 
colonies turn blue, due to the production of the indole coproduct, 
which reacts with Ehrlich’s reagent (Plate 2). After 1-hour 
incubation (Plates 3 & 4), no significant background was evident 
in the KO strain. These results demonstrate the power of this 
solid-phase assay for the high-throughput screening of large TA 
libraries using this novel expression strain.  
 
 
Figure 4. High-throughput solid-phase screen employing the E. coli BL21(DE3) 
ΔtnaA tryptophanase knock-out strain, alongside BL21(DE3). 1) 2-AEA (11 
mM), 30 min incubation at r.t. 2) 2-AEA (11 mM), pyruvate (10 mM), 30 min 
incubation 3) 2-AEA (11 mM), 1 h incubation at r.t. 4) 2-AEA (11 mM), pyruvate 
(10 mM), 1 h incubation at r.t. See SI for details. 
 
In summary, we have developed a comprehensive and simple 
assay for amine transaminases, which enables rapid 
spectrophotometric identification of enzymes with activity towards 
both novel amine donor and acceptor substrates, as well as 
allowing the enantio-preference of the biocatalysts to be profiled. 
The screen relies on the reaction of in situ produced or 
exogenously added indole with Ehrlich’s reagent and its 
derivatives and has been demonstrated to work with both 
commercially available ATAs as well as wild-type enzymes. An 
engineered expression strain lacking tryptophanase activity, E. 
coli BL21(DE3) ΔtnaA, has also been developed, and the strain 
used to design a colony-based solid-phase screen. This strain will 
be made freely available to academic and industrial teams who 
wish to carry out library screening. The assay has potential to 
simplify and expedite directed evolution of ATAs, particularly in 
the absence of expensive robotics platforms, and become the 
screening method of choice for the identification of novel 
substrates.   
 
Experimental 
Acceptor screen 
The colorimetric screen was performed by adding a sample of the 
biotransformation (10 µL) to a well containing 90 µL of a mixture 
of DMSO:H2O/9:1 and mixed thoroughly. To this was added 100 
µL of a solution of p-dimethylaminobenzaldehyde (0.67 M in 
EtOH:HCl (1:1)) and  the solution was mixed thoroughly. The 
colour was allowed to develop for 30 minutes and a spectral scan 
of the plate was performed on an EPOCH 2 microplate reader 
(BioTek Instruments) from 470-600 nm. The maximum absorption 
was recorded as 572 nm. 
Donor screen 
The colorimetric screen was performed by diluting the 
biotransformations (40 µL) in biotransformation buffer (160 µL). 
50 µL of the resulting solution was transferred to a well containing 
indole (50 µL, 50 mM in DMSO) and mixed thoroughly. To this 
was added DMSO/HCl (100 µL, 1:1 (v/v)) and the solution was 
mixed thoroughly. The colour was developed for 8 minutes under 
white light. A spectral scan of the plate was then performed on an 
EPOCH 2 microplate (BioTek Instruments) reader from 500-530 
nm. The maximum absorption was recorded at 518 nm. 
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